DESMOID TUMOUR

This adverse event was reported 210 times

DESMOID TUMOUR is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Actinomycin [EPC] 6 0.0027
1 Lymphocyte Growth Factor [EPC] 2 0.0016
2 Gamma Secretase Inhibitor [EPC] 1 0.0011
3 Leptin Analog [EPC] 1 0.0008
4 GLP-2 Analog [EPC] 3 0.0002
5 SLAMF7-directed Immunostimulatory Antibody [EPC] 1 0.0002
6 Allylamine Antifungal [EPC] 1 0.0001
7 Progesterone [EPC] 3 0.0001
8 Vitamin K [EPC] 1 0.0001
9 CD52-directed Cytolytic Antibody [EPC] 2 0.0001
See all drug classes enriched for association with DESMOID TUMOUR